1. Home
  2. ESNT vs ALKS Comparison

ESNT vs ALKS Comparison

Compare ESNT & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Essent Group Ltd.

ESNT

Essent Group Ltd.

HOLD

Current Price

$63.94

Market Cap

5.9B

Sector

Finance

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$34.85

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESNT
ALKS
Founded
2008
1987
Country
Bermuda
Ireland
Employees
N/A
1800
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
5.8B
IPO Year
2013
1991

Fundamental Metrics

Financial Performance
Metric
ESNT
ALKS
Price
$63.94
$34.85
Analyst Decision
Buy
Strong Buy
Analyst Count
7
13
Target Price
$68.71
$42.85
AVG Volume (30 Days)
757.1K
2.2M
Earning Date
02-13-2026
02-13-2026
Dividend Yield
1.90%
N/A
EPS Growth
N/A
2.44
EPS
6.87
2.02
Revenue
$1,263,558,000.00
$1,521,338,000.00
Revenue This Year
$3.55
N/A
Revenue Next Year
$1.24
$23.22
P/E Ratio
$9.50
$17.34
Revenue Growth
2.04
1.08
52 Week Low
$51.61
$25.17
52 Week High
$67.09
$36.45

Technical Indicators

Market Signals
Indicator
ESNT
ALKS
Relative Strength Index (RSI) 53.09 64.06
Support Level $60.92 $33.35
Resistance Level $66.36 $35.02
Average True Range (ATR) 1.29 1.18
MACD 0.35 0.01
Stochastic Oscillator 59.09 82.98

Price Performance

Historical Comparison
ESNT
ALKS

About ESNT Essent Group Ltd.

Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: